These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Lung Function and CT Densitometry in Subjects with alpha-1-Antitrypsin Deficiency and Healthy Controls at 35 Years of Age. Piitulainen E; Montero LC; Nystedt-Düzakin M; Stoel BC; Sveger T; Wollmer P; Tanash HA; Diaz S COPD; 2015 Apr; 12(2):162-7. PubMed ID: 25280185 [TBL] [Abstract][Full Text] [Related]
27. Lung function in alpha1-antitrypsin heterozygotes (Pi type MZ). Cooper DM; Hoeppner V; Cox D; Zamel N; Bryan AC; Levison H Am Rev Respir Dis; 1974 Dec; 110(6):708-15. PubMed ID: 4547935 [No Abstract] [Full Text] [Related]
28. Protease inhibitor profile of black Americans with and without chronic cardiopulmonary disease. Young RC; Headings VE; Henderson AL; Bose S; Hackney RL J Natl Med Assoc; 1978 Nov; 70(11):849-56. PubMed ID: 309951 [TBL] [Abstract][Full Text] [Related]
29. Protease inhibitors in chronic obstructive pulmonary disease. Barnett TB; Gottovi D; Johnson AM Am Rev Respir Dis; 1975 May; 111(5):587-93. PubMed ID: 1079422 [TBL] [Abstract][Full Text] [Related]
30. Physiological studies in a large sibship with antitrypsin deficiency. Duncan PE; Griffin JP Br J Dis Chest; 1975 Apr; 69(2):107-17. PubMed ID: 49190 [TBL] [Abstract][Full Text] [Related]
31. Pulmonary function in children with homozygous alpha1-protease inhibitor deficiency. Wiebicke W; Niggemann B; Fischer A Eur J Pediatr; 1996 Jul; 155(7):603-7. PubMed ID: 8831086 [TBL] [Abstract][Full Text] [Related]
32. Relation of protease inhibitor phenotypes to obstructive lung diseases in a community. Morse JO; Lebowitz MD; Knudson RJ; Burrows B N Engl J Med; 1977 May; 296(21):1190-4. PubMed ID: 300842 [TBL] [Abstract][Full Text] [Related]
33. The Swedish α1-Antitrypsin Screening Study: Health Status and Lung and Liver Function at Age 34. Tanash HA; Nystedt-Düzakin M; Montero LC; Sveger T; Piitulainen E Ann Am Thorac Soc; 2015 Jun; 12(6):807-12. PubMed ID: 25803183 [TBL] [Abstract][Full Text] [Related]
35. The Clinical Profile of Subjects Included in the Swedish National Register on Individuals with Severe Alpha 1-Antitrypsin deficiency. Piitulainen E; Tanash HA COPD; 2015 May; 12 Suppl 1():36-41. PubMed ID: 25938290 [TBL] [Abstract][Full Text] [Related]
36. Pulmonary emphysema associated with the FZ alpha 1-antitrypsin phenotype. Cockcroft DW; Tennent RK; Horne SL Can Med Assoc J; 1981 Mar; 124(6):737-42. PubMed ID: 6970613 [TBL] [Abstract][Full Text] [Related]
37. Family study of alpha 1-antitrypsin deficiency: effects of cigarette smoking, measured genotype, and their interaction on pulmonary function and biochemical traits. Silverman EK; Province MA; Campbell EJ; Pierce JA; Rao DC Genet Epidemiol; 1992; 9(5):317-31. PubMed ID: 1427021 [TBL] [Abstract][Full Text] [Related]
38. Alpha1-antitrypsin deficiency: genetic, clinical and functional correlations in a three generation family. Perrault JL; Malo JL; Bake B; Renzi G; Grassino A Respiration; 1979; 37(5):291-300. PubMed ID: 314139 [TBL] [Abstract][Full Text] [Related]
39. Longitudinal decline of diffusing capacity of the lung for carbon monoxide in community subjects with the PiMZ alpha1-antitrypsin phenotype. Silva GE; Guerra S; Keim S; Barbee RA; Sherrill DL Chest; 2008 May; 133(5):1095-100. PubMed ID: 18263681 [TBL] [Abstract][Full Text] [Related]
40. Convective gas mixing, airway dimensions and lung function parameters in patients homo- or heterozygote for hereditary alpha1-antitrypsin deficiency. Siekmeier R; Schiller-Scotland CF Toxicol Lett; 1998 Aug; 96-97():325-33. PubMed ID: 9820684 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]